Directs the department of health to establish an alternative payment methodology (APM) for federally qualified health centers to preserve and improve patient access to fertility care.
Summary
This bill directs the New York State Department of Health to create an alternative payment methodology (APM) for federally qualified health centers (FQHCs) to help preserve and improve access to fertility care. The measure is tied to existing state plan amendment authority and is intended to provide additional payments on top of the standard prospective payment system (PPS) or any other existing APM available to eligible FQHCs.
The bill specifies that the APM would cover the difference between what an eligible provider would have been paid for certain fertility drugs under the federal 340B program during calendar year 2024 and what the provider would have been reimbursed by a managed care organization if the drugs were covered. The eligible fertility drugs are limited to gonadotropin, GnRH antagonists, and GnRH agonists. The bill takes effect immediately.
Impact
The bill would require the Department of Health to establish a new reimbursement mechanism for FQHCs that provide fertility-related medications, effectively creating a supplemental payment stream for those providers. It would affect state Medicaid-related payment policy and could increase reimbursement for safety-net clinics that serve patients seeking fertility care, particularly where managed care reimbursement is lower than 340B-based acquisition costs. The measure does not amend the underlying eligibility of patients for fertility services, but it could improve provider capacity to offer or maintain access to those drugs.
Sentiment
No committee transcript or vote record is available, so there is no documented debate or formal vote history to gauge support or opposition. Based on the bill’s purpose and narrow scope, the measure appears designed as a targeted access-and-reimbursement fix for community health centers rather than a broader policy change. The overall framing is supportive of fertility care access and of financial stability for FQHCs.
Contention
The main potential point of contention is fiscal and administrative: the bill would obligate the Department of Health to set a payment methodology that makes up the gap between 340B-related costs and managed care reimbursement, which could raise program costs or require new administrative rules. Another likely issue is the narrow scope of the benefit, since it is limited to federally qualified health centers and to specific fertility drugs, which may prompt questions about why other providers, medications, or fertility-related services are excluded. No specific opposing or supporting stakeholders are identified in the available record.
Directs the department of health to establish an alternative payment methodology (APM) for federally qualified health centers to preserve and improve patient access to fertility care.
Directs the department of health to establish an alternative payment methodology (APM) for federally qualified health centers to preserve and improve patient access to fertility care.
Directs the department of health to establish an alternative payment methodology (APM) for federally qualified health centers to preserve and improve patient access to fertility care.
Requires Medicaid and NJ FamilyCare managed care organizations to offer patient-centered medical home model or other alternative payment model to primary care providers.
Patient-Centered Care program established, direct state payments to health care providers authorized, contracting with administrative services organizations authorized, conforming changes made, and money appropriated.
Health plans required to cover infertility treatment and standard fertility preservation services, medical assistance and MinnesotaCare required to cover infertility treatment and standard fertility preservation services, and money appropriated.
Health plans required to cover infertility treatment and standard fertility preservation services, medical assistance and MinnesotaCare required to cover infertility treatment and standard fertility preservation services, and money appropriated.